Starpharma's [ASX:SPL] Viraleze Nasal Spray Receives Approval in Malaysia
Biotech Starpharma has received regulatory approval for its Viraleze product to be used in Malaysia, adding the product to a wider market base that now spans 35 countries as it looks into further COVID-19 studies in the UK.